US Patent Issued to Kainos Medicine on Jan. 27 for "N-(1H-imidazol-2-yl)benzamide compound and pharmaceutical composition comprising the same as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,452, issued on Jan. 27, was assigned to Kainos Medicine Inc. (Seongnam-si, South Korea).

"N-(1H-imidazol-2-yl)benzamide compound and pharmaceutical composition comprising the same as active ingredient" was invented by Jaeuk Chung (Seongnam-si, South Korea), Sunmi Kim (Seongnam-si, South Korea), Hanyang Cho (Seongnam-si, South Korea) and Jiyoung Min (Seongnam-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "N-(1H-imidazol-2-yl)benzamide compound of formula (I), or a pharmaceutically acceptable salt, a prodrug, a solvate, or a stereoisomer thereof which is a novel compound exhibiting excellent inhibitory activity against IRAK-4, can be u...